They investigated 12 medications — three that the US Food and Drug Administration (FDA) has approved for weightloss and nine it hasn’t. The drugs mimic GLP-1, a hormone the body naturally ...
GLP-1 drugs such as Ozempic, Wegovy and Zepbound are growing in popularity to treat patients in need of significant weightloss, but they're expensive. Medicaid programs in 13 states cover ...
It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weightloss market ... product is an oral-based GLP-1, a drug that curbs hunger.